Our Recommendations
- Tropical Medicine Point-of-Care Testing. Update 2022 (2022)
- Manual de Biossegurança Laboratorial (2021)
- Recommendations for national SARS-CoV-2 testing strategies and diagnostic capacities (2021)
- Serology-based tests for COVID-19 (2020)
- Specimen referral for 2019nCoV - operational details of referral laboratories (2020)
New Publications
- Directrices de Laboratorio para la Detección y el Diagnóstico de la Infección con el coronavirus del Síndrome Respiratorio del Medio Oriente (MERS–CoV) (2022)
- Note d’orientation de l’OMS : tests de diagnostic de la COVID-19 (2022)
- Tropical Medicine Point-of-Care Testing. Update 2022 (2022)
- WHO policy brief: COVID-19 testing, 14 September 2022 (2022)
- Manual de Biossegurança Laboratorial (2021)
Filter
137
Featured
Recommendations
39
Language
Document type
Guidelines
81
Fact sheets
20
Manuals
10
Training Material
5
Studies & Reports
5
Online Courses
5
Videos
4
Resource Platforms
3
Infographics
3
No document type
1
Countries / Regions
Germany
14
Russia
11
East and Southern Africa
9
Africa
8
West and Central Africa
7
Brazil
7
Latin America and the Carribbean
6
Mozambique
4
Global
4
Middle East and North Africa
4
Eastern Europe and Central Asia
4
Angola
4
Spain
2
South Africa
2
China
1
Kazakhstan
1
Guinea-Bissau
1
Western Pacific Region
1
Western and Central Europe
1
Eastern Europe
1
Authors & Publishers
Publication Years
Category
Countries
50
Pharmacy & Technologies
19
Capacity Building
3
Public Health
1
Key Resources
1
This policy guideIine is intended for use by healthcare professionals invoIved in the management of Covid-19 in South Africa. The document provides guidance on diagnostic tests available, on antigen test performance and accessibility. 1t focuses on key issues such as when to
Perform antigen tests...
Technical specifications for selection of essential in vitro diagnostic tests for SARS-COV-2, 14 June 2021
Esta quarta edição do manual se baseia no esquema de avaliação de risco apresentado na terceira edição. Uma avaliação completa, baseada em evidências e transparente dos riscos permite que as medidas de segurança sejam equilibradas com o risco real de trabalhar com agentes biológicos, caso...
TECHNICAL SPECIFICATIONS FOR TEST SELECTION ESSENTIAL IN VITRO DIAGNOSTIC TESTS FOR SARS-COV-2
Manual de Biossegurança Laboratorial
recommended
Quarta Edição.
Esta quarta edição do manual se baseia no esquema de avaliação de risco apresentado na terceira edição. Uma avaliação completa, baseada em evidências e transparente dos riscos permite que as medidas de segurança sejam equilibradas com o risco real de trabalhar com agentes...
Laboratory biosafety manual
recommended
4th edition
The WHO Laboratory Biosafety Manual (LBM) has been in broad use at all levels of clinical and public health laboratories, and other biomedical sectors globally, serving as a de facto global standard that presents best practices and sets trends in biosafety.
LBM encouraged countries t...
The following protocol has been designed to investigate the First Few X cases (FFX) and their close contacts. It is envisioned that the FFX 2019-nCoV investigation will be conducted across several countries or sites with geographical and demographical diversity. Using a standardized protocol such a...
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China.
19 March 2020
Protocol and preliminary evaluationas of Jan 17, 2020
Countries who have no testing capacity can send their samples to the WHO appointed 2019-nCoV referral laboratories for testing. National 2019-nCoV laboratories with limited experience are encouraged to send the first five positives and the first ten negative 2019-nCoV samples to their referral labor...
En enero de 2020, el agente etiológico responsable de un grupo de casos de neumonía grave en Wuhan, China, fue identificado como un nuevo betacoronavirus (2019-nCoV), distinto del SARS-CoV y MERS-CoV (1) (2) (3). La secuencia genómica completa de este nuevo agente está disponible y se han desarr...
Временные рекомендации
17 января 2020 г.
Цель настоящего документа – предоставить временные рекомендации лабораториям и субъектам, занятым в работах по лаборатор...
For SARS-CoV-2 testing only
Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-...
Временное руководство
19 марта 2020 г.
Данный документ предоставляет временное руководство лабораториям и заинтересованным сторонам, участвующим в лабораторном ...
